Merck & Co., Inc. (6MK0)

Profile

https://www.merck.com

Merck & Co., Inc. is a leading global healthcare company specializing in the discovery, development, manufacturing, and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical segment features blockbuster drugs like Keytruda, a leading immuno-oncology treatment for various cancers; Gardasil for human papillomavirus prevention; and others addressing cardiometabolic diseases, infections, and hospital-acquired conditions, including Welireg, Winrevair, and Januvia. Merck also maintains a robust vaccine portfolio with products such as ProQuad, Vaxneuvance, and RotaTeq targeting pediatric diseases. The animal health division provides solutions like Nuflor and Bovilis for livestock and companion animals, supporting disease prevention and management. Headquartered in Rahway, New Jersey, and founded in 1891, Merck operates worldwide, with significant U.S. sales from human health products. Employing around 75,000 people, the company plays a pivotal role in advancing treatments for cancer, infectious diseases, and veterinary care, contributing substantially to the pharmaceutical and biotechnology sectors.